Archive for May, 2007
« Previous EntriesMylan Announces Final FDA Approval For Fluoxetine Capsules USP, 40 Mg
Thursday, May 31st, 2007Mylan Laboratories Inc. (NYSE: MYL) announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its supplemental Abbreviated New Drug Application (ANDA) for Fluoxetine Capsules USP, 40 mg. Fluoxetine Capsules are the generic version of Eli Lilly and Company’s Prozac(R) Capsules. Fluoxetine Capsules had U.S. [click link for full article]
Antidepressant Use May Boost Fracture Risk, From Harvard Women’s Health Watch
Wednesday, May 30th, 2007Evidence is accumulating that depression is a risk factor for osteoporosis, reports the June 2007 issue of Harvard Women’s Health Watch. A recent study found that people ages 50 and over who regularly took antidepressants called selective serotonin reuptake inhibitors (SSRIs) had double the rate of fractures as people not using such medications. Other research points to depression itself as a source of endocrine changes that can damage bone. [click link for full article]
In New Study, Duloxetine Was Equally Effective, Regardless Of Switch Method, In Reducing Painful Symptoms In SSRI
Monday, May 28th, 2007The antidepressant duloxetine hydrochloride was equally effective in reducing painful symptoms in depressed patients who did not respond, or responded only partially, to treatment with a selective serotonin reuptake inhibitor (SSRI), regardless of whether those patients were switched from an SSRI abruptly or gradually.1 This new data was presented today at the American Psychiatric Association´s 160th Annual Meeting in San Diego, Calif. [click link for full article]
What Is Really Important When You Are Depressed?
Monday, May 28th, 2007What are the values and inconsistencies in patients who are depressed? A group of investigators of the University of Jena has attempted to identify these aspects in the May issue of Psychotherapy and Psychosomatics. In this study, the Authors used the Intrapersonal Conflict Test to assess cognitive inconsistencies in goals or values. [click link for full article]
How Depression Begins: Look At Warning Signs
Monday, May 28th, 2007Giovanni Fava and Eliana Tossani of the University of Bologna review the literature on how depressive illness begins. Depression does not come out of the blue. There are clear warning signs that patients should know and allow an early intervention.The aim of this review was to survey the available literature on prodromal symptoms of unipolar major depression. Both a computerized (Medline) and a manual search of the literature were performed. [click link for full article]
Study Tests Depression Treatment For Diabetes Patients
Monday, May 28th, 2007In Appalachia, diabetes hits hard. Depression does, too. Together, they form a difficult pair to beat. To help patients fight back, a team of Ohio University College of Osteopathic Medicine (OU-COM) and Ohio University researchers have put together a new approach to the double-edged problem. [click link for full article]
Workplace Burden Of Depression Magnified By Co-morbid Fatigue And Anxiety, New Study Shows
Monday, May 28th, 2007Depression, well known to reduce workplace productivity, causes significantly greater productivity declines when accompanied by common co-occurring conditions such as fatigue, sleep problems or anxiety, according to a large new study presented today at the American Psychiatric Association’s 160th Annual Meeting in San Diego.[i] The study also showed that co-occurring fatigue or sleep problems significantly increased depression-related healthcare costs. [click link for full article]
Efficacy And Safety Of Aripiprazole As Adjunctive Therapy In Major Depressive Disorder
Monday, May 28th, 2007In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score. In this six-week, randomized, placebo-controlled study presented here at the 160th Annual Meeting of the American Psychiatric Association, the Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. [click link for full article]
Greater Risk Of Depression In Persistent Smokers Than Never Smokers
Sunday, May 27th, 2007Based on a Finnish study, persistent smokers may have higher risk of becoming depressed in comparison to never smokers. Also those smokers who quit have an elevated risk of depressive symptoms in the short run. However, in the long run this risk declines to the level of never smokers. In other words, both completely smoke-free life style and successful smoking cessation in the long run seem to protect from depressive symptoms. [click link for full article]
Families Of Dying Patients Suffer Reduced Stress, Anxiety And Depression When Communication Improved
Saturday, May 26th, 2007Hospitals that use a simple strategy of enhancing communication with family members of patients dying in the intensive care unit can greatly reduce post-traumatic stress disorder, anxiety and depression after their loved one dies, according to a study to be presented at the American Thoracic Society International Conference in San Francisco on Monday, May 21. [click link for full article]
« Previous Entries